Lithium Carbonate
NDC 68462-223, Lithium Carbonate, tablet, film coated, extended release, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-223
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091544
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LITHIUM CARBONATE300 mg/1
Pharmacologic classes
Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-223-01 | 68462022301 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-223-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1b65d27e-5086-4a87-8387-c49f3d060978NADAC price for package 68462022301
GET /v1/drugs/nadac/68462022301
Use it
Look up 68462-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.